In today’s briefing:
- Sungho Electronics – Significantly Undervalued Vs RoboTechnik’s Recent IPO in Hong Kong
- Primer: Osstem Implant (048260 KS) – Oct 2026
Sungho Electronics – Significantly Undervalued Vs RoboTechnik’s Recent IPO in Hong Kong
- Sungho Electronics is trading at 49% and 39% discount to Robotechnik in terms of their 2027 and 2028 consensus earnings estimates, respectively.
- Sungho Electronics is trading at 94% and 93% discount to Robotechnik based on P/B valuation multiples in 2027 and 2028, respectively.
- Consensus estimates Sungho Electronics’ operating profit to increase from 7.6 billion won in 2025 to 41 billion won in 2026 and 108.1 billion won in 2027.
Primer: Osstem Implant (048260 KS) – Oct 2026
- Global Volume Leadership and Scaled Commercial Footprint: Osstem Implant maintains the world’s #1 market share position in dental implants by sales volume, driven by its proprietary AIC dentist training network, comprehensive direct-sales subsidiary infrastructure, and competitive value-segment pricing.
- Margin Inflection Following VBP Disruption: While top-line revenue expanded steadily from KRW 1.21T in FY23 to KRW 1.33T in FY25, operating and net margins absorbed significant headwinds from China’s centralized Volume-Based Procurement (VBP) pricing before demonstrating a decisive margin inflection in 1H26 (EBITDA margin rebounding to 21.4% in 2Q26).
- Private Equity Governance and Operational Modernization: Following the privatization led by MBK Partners and Unison Capital, corporate governance and financial controls have been substantially upgraded, positioning the firm for enhanced capital discipline, overseas direct-sales expansion (Hiossen), and digital dentistry bundling.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

